PRCT 10 Year Annualized Return and Average Annual Return

PRCT Average Annual Return Chart Since 2021
Growth of $10,000.00
Without Dividends Reinvested Into PRCT

Also see:
• PRCT stock yearly return 2021
• PRCT stock yearly return 2022
• PRCT stock yearly return 2023
• PRCT stock yearly return 2024
• PRCT stock yearly return 2025
• PRCT YTD return
Average Annual Return Benchmarks
Compare PRCT average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
PRCT Share Performance
PRCT Average Annual Return Table Since 2021
Start date: 09/16/2021
End date: 10/09/2026
Start price/share: $35.91
End price/share: $18.40
Dividends collected/share: $0.00
Total return: -48.76%
PRCT Average Annual Return: -12.37%
Starting investment: $10,000.00
Ending investment: $5,122.63
Years: 5.07


PRCT average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
About PROCEPT BioRobotics Corp
PROCEPT BioRobotics is a surgical robotics company dedicated to advancing urology care. Co. develop, manufacture, and sell the AquaBeam Robotic System, an image-guided system for minimally invasive urologic surgery, primarily for treating benign prostatic hyperplasia (BPH). The AquaBeam system uses a single-use handpiece to deliver Aquablation therapy, which combines real-time imaging, personalized treatment planning, automated robotics, and heat-free waterjet ablation for precise prostate tissue removal. This therapy aims to provide effective, safe, and durable outcomes for men with lower urinary tract symptoms due to BPH, regardless of prostate size, shape, or surgeon experience. The PRCT average annual return since 2021 is shown above.

The Average Annual Return on the PRCT average annual return since 2021 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether PRCT average annual return since 2021 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the PRCT average annual return calculation with any dividends reinvested as applicable (on ex-dates).
PRCT Current Stock Quote
Quotes delayed 20 minutes

Email EnvelopeFree PRCT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
Featured Slideshows
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!
Video: Don't Forget Dividends in Average Annual Return!
Average Annual Return Peers
PROCEPT BioRobotics (PRCT) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

PRGO Average Annual Return
PRLD Average Annual Return
PRME Average Annual Return
PROK Average Annual Return
PRPH Average Annual Return
PRPO Average Annual Return
PRTA Average Annual Return
PRTO Average Annual Return
PRVA Average Annual Return
PSNL Average Annual Return
More Healthcare companies »
 

PRCT 10 Year Annualized Return & Average Annual Return | www.AverageAnnualReturn.com | Copyright © 2021 - 2026, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.